3117.0 Infectious Disease Epidemiology

Monday, October 27, 2008: 10:30 AM
Oral
This informative session will focus on the epidemiology of a potpourri of infectious diseases. Presentations will include discussions of leptospirosis, botulism, and meningococcal disease. The relationship between time since onset of injection drug use and hepatitis C infection and depression and substance abuse in a hepatitis C register will be discussed in other presentations.
Session Objectives: At the conclusion of the session, the participant (learner) will be able to: 1. List two host factors associated with leptospirosis in Hawaii 2. Identify the difference between age at onset of botulism between breast-fed and formula-fed infants 3. Describe the relationship between time since onset of drug injection and HCV incidence and prevalence rates in injection drug users 4. Discuss prevalence of mental health disorders and substance abuse in persons with newly-reported HCV infection 5. Compare the reported side effects of ciprofloxacin given at a distribution clinic with published studies
Moderator:
Elizabeth Bancroft, MD, SM

Introductory Remarks
10:35 AM
Leptospirosis in Hawaii: 1999-2006: Epidemiologic and clinical analysis of 174 laboratory-confirmed cases
Alan R. Katz, MD, MPH, Kialani L. Hinson, MPH, Arlene E. Buchholz, DVM, MPH, Erick T. Cremer, RN, MPH and Paul V. Effler, MD, MPH
     
10:50 AM
Descriptive epidemiology of infant botulism in the United States, 1976-2006
Jessica R. Payne, MPH, Jeremy Sobel, MD, MPH and Stephen S. Arnon, MD
11:05 AM
Meta-regression of hepatitis C virus (HCV) infection in relation to time since onset of illicit drug injection
Holly Hagan, PhD, Enrique R. Pouget, Corina Lelutiu-weinberger, PhD and Don C. Des Jarlais, PhD
     
11:20 AM
Prevalence of depression and substance abuse in a population-based hepatitis C registry, Multnomah County, Oregon
Grace R. Van Ness, MPH, CHES, Atif Zaman, MD, MPH, Ann Thomas, MD MPH, Diata D. Rhodes, MA, Kathy Boaz Dhotre, MPH, Stephanie R. Bialek, MD, MPH and Beth P. Bell, MD, PhD
11:35 AM
Side effects from ciprofloxacin following meningococcal disease prophylaxis in a high school
Van P. Ngo, MPH, Rachel Civen, MD, MPH, David E. Dassey, MD, MPH, Deborah Davenport, RN, MS and Laurene Mascola, MD, MPH
     
Concluding Remarks

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Epidemiology

CE Credits: CME, Health Education (CHES), Nursing

See more of: Epidemiology
<< Previous Session | Next Session >>